This is a review about GSK3beta, based on 63 published articles (read how Labome selects the articles), using GSK3beta antibody in all methods. It is aimed to help Labome visitors find the most suited GSK3beta antibody.
GSK3beta synonym: GSK-3 beta; GSK3beta isoform; glycogen synthase kinase-3 beta; serine/threonine-protein kinase GSK3B

gallery
Cell Signaling TechnologyCell Signaling Technology GSK3beta product
  • immunocytochemistryIn 2005, Roman Kulikov et al. employed Cell Signaling Technology GSK3beta antibody to investigate the regulation of p53 by GSK through MDM2 [ncbi , more ].
  • immunohistochemistryDeliang Guo et al. applied Cell Signaling Technology GSK3beta antibody to investigate the mechanism of how Akt mediates sterol regulatory element-binding protein 1 (SREBP-1) cleavage induced by EGFR [ncbi , more ] in 2009 and Melanie Konigshoff et al. used Cell Signaling Technology GSK3beta antibody to investigate the role of WISP1 in the regulation of ATII cell hyperplasia and plasticity [ncbi , more ]. In 2008, Melanie Konigshoff et al. used Cell Signaling Technology GSK3beta antibody to quantify and localize the expression and activity of the Wnt/beta-catenin pathway in IPF [ncbi , more ].
  • immunoprecipitationIn 2005, Roman Kulikov et al. employed Cell Signaling Technology GSK3beta antibody to investigate the regulation of p53 by GSK through MDM2 [ncbi , more ].
  • western blotIn 2012, Shu Yong Lin et al. utilized Cell Signaling Technology GSK3beta antibody to perform western blot in order to investigate the role of GSK3-TIP60-ULK1 signaling pathway in autophagy [ncbi , more ]. Cell Signaling Technology GSK3beta antibody was applied in 2010 to investigate the role of N-WASP in the regulation of Wnt signaling and hair follicle cycling in mice [ncbi , more ], to investigate the role of CDC5 in the regulation of the checkpoint kinase Rad53 hyperphosphorylation [ncbi , more ]and to perform western blot in order to study the role of LMP2A in the nasopharyngeal carcinoma progression [ncbi , more ]. Cell Signaling Technology GSK3beta antibody was used in 2009 to investigate the role of WISP1 in the regulation of ATII cell hyperplasia and plasticity [ncbi , more ], to investigate the role of NDRG2 in the regulation of TCF/beta-catenin signaling in human colon carcinoma [ncbi , more ], to investigate the role of PTEN phosphorylation in the regulation of ATP-sensitive K+ channels [ncbi , more ], to investigate the role of the Snail1 in the regulation of three-dimensional invasion by mesenchymal cells [ncbi , more ], to study the role of PI3K in modulating cytokine production from primary human monocytes after cross-linking the CD16 receptor [ncbi , more ], to perform western blot in order to study the roles of S100B protein during the astrocyte shape and migration [ncbi , more ], to study the role for bone morphogenetic protein 2 in inducing pulmonary angiogenesis and its mechanism [ncbi , more ], to evaluate the potential relevance of ApoER2 for APC cell signaling mechanisms [ncbi , more ], to show that Hsp90 co-chaperone CDC37 can maintain the oncogenic protein kinase clients [ncbi , more ]and to show that adiponectin haploinsufficiency can promote mammary tumorigenesis through inhibition of PTEN activity and activation of PI3K/Akt signalling pathway [ncbi , more ]. Cell Signaling Technology GSK3beta antibody was used in 2008 to test the hypothesis that HGF suppresses renal inflammation by inhibiting proinflammatory cytokine expression [ncbi , more ], to quantify and localize the expression and activity of the Wnt/beta-catenin pathway in IPF [ncbi , more ], to identify the pathway and mechanism by which AAs signal to hVps34 to stimulate mTOR complex1 signaling [ncbi , more ], to examine the effects of combining a proteasome inhibitor with an HDAC inhibitor in GBM cell lines [ncbi , more ], to investigate the mechanism of how insulin signaling pathway and glucose metabolism were affected by the inhibitor of nuclear factor-kappa B [ncbi , more ], to perform western blot in order to study how genistein regulate tumor suppressor genes in prostate cancer cells [ncbi , more ], to study molecular mechanisms underlying TSH-secreting pituitary tumors (TSHomas) [ncbi , more ], to study the role of Gsk-3beta in control of beta-cell mass in insulin-resistant diabetic models [ncbi , more ], to demonstrate that lithium suppresses Smad3/4-dependent TGF-beta-responsive gene transactivation [ncbi , more ]and to demonstrate that increased AA and insulin availability causes changes in anabolic signaling and amounts of enzymes of the ubiquitin-proteasome pathway [ncbi , more ]. In 2006, Mariko Tomita et al. employed Cell Signaling Technology GSK3beta antibody to study the effect of Jak-Stat pathway on cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells [ncbi , more ]. Cell Signaling Technology GSK3beta antibody was utilized in 2005 to investigate the regulation of p53 by GSK through MDM2 [ncbi , more ], to investigate the activation of phosphatidylinositol 3-kinase/Akt and transformation by NBS1 [ncbi , more ], to investigate the role of integrin-linked kinase in Akt phosphorylation and fibroblast survival [ncbi , more ], to the angiogenic phenotype regulation by mitochondrial H2O2 via PTEN oxidation [ncbi , more ], to study that kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via akt-glycogen synthase kinase-3 and akt-bad 14-3-3 signaling pathways [ncbi , more ]and to study RhoB protective effect from UVB-induced apoptosis in human keratinocytes [ncbi , more ]. Cell Signaling Technology GSK3beta antibody was utilized in 2004 to detect phospho-GSK-3beta in HeLa cells treated with or without calyculin A [ncbi , more ], to study interleukin 7 effects on T cell acute lymphoblastic leukemia cells [ncbi , more ], to detect phospho-GSK-3 beta in B-lymphoid precursor cell line, Reh [ncbi , more ], to study expression of secreted frizzled-related protein 4 in normal and malignant human prostate tissue. [ncbi , more ]and to evaluate therapeutic potential of the combination of IGFBP-3 and SCH66336 [ncbi , more ]. In 2003, Gustavo Pigino et al. utilized Cell Signaling Technology GSK3beta antibody to study the function of presenilin 1 mutations in kinesin-based axonal transport [ncbi , more ]. Cell Signaling Technology GSK3beta antibody was applied in 2002 to study cell survival by GLP-2R signaling [ncbi , more ], to study the mechanism by which WISP-1 promotes tumorigenicity [ncbi , more ]and to study the phosphorylation of GSK-3 [ncbi , more ]. E Avota et al. applied Cell Signaling Technology GSK3beta antibody to study the MV interference with Akt activation during immunosuppression [ncbi , more ] in 2001 and T Wada et al. used Cell Signaling Technology GSK3beta antibody to study the effect of SH2-containing inositol phosphatase 2 in 3T3-L1 adipocytes [ncbi , more ].
EMD MilliporeEMD Millipore GSK3beta product
  • immunocytochemistryIn 2003, Gustavo Pigino et al. utilized EMD Millipore GSK3beta antibody to study the function of presenilin 1 mutations in kinesin-based axonal transport [ncbi , more ].
  • immunoprecipitationIn 2001, G A Turenne et al. utilized EMD Millipore GSK3beta antibody to perform immunoprecipitation in order to show that p53 could be activated by GSK3beta through phosphorylation of S33 [ncbi , more , fig ].
  • western blotIn 2009, Michel Varrin-Doyer et al. applied EMD Millipore GSK3beta antibody to perform western blot in order to investigate the molecular mechanisms underlying CRMP2 function in CXCL12-induced T lymphocyte migration [ncbi , more ]. In 2005, Michael N Corradetti et al. utilized EMD Millipore GSK3beta antibody to study the negative regulation of the mammalian target of rapamycin pathway by the stress-inducted proteins RTP801 and RTP801L [ncbi , more ]. In 2003, Gustavo Pigino et al. utilized EMD Millipore GSK3beta antibody to study the function of presenilin 1 mutations in kinesin-based axonal transport [ncbi , more ].
AbcamAbcam GSK3beta product
  • western blotIn 2010, Yuping Luo et al. used Abcam GSK3beta antibody to perform western blot in order to study the roles of the fragile X mental retardation protein during the regulations of the proliferation and differentiation of adult neural stem/progenitor cells [ncbi , more ].
Santa Cruz BiotechnologySanta Cruz Biotechnology GSK3beta product
  • immunoprecipitationIn 2003, Jin Woo Kim et al. employed Santa Cruz Biotechnology GSK3beta antibody to detect GSK3beta in HEK293 cells transfected with plasmid encoding HA-MEKK1 either alone or together with plasmids for GSK3beta-FLAG [ncbi , more ].
  • western blotIn 2012, Shu Yong Lin et al. utilized Santa Cruz Biotechnology GSK3beta antibody to perform western blot in order to investigate the role of GSK3-TIP60-ULK1 signaling pathway in autophagy [ncbi , more ]. Xia V Yang et al. utilized Santa Cruz Biotechnology GSK3beta antibody to evaluate the potential relevance of ApoER2 for APC cell signaling mechanisms [ncbi , more ] in 2009 and Anna Dubrovska et al. used Santa Cruz Biotechnology GSK3beta antibody to study the role for PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations [ncbi , more ]. Lee Eun Jeoung et al. employed Santa Cruz Biotechnology GSK3beta antibody to demonstrate that SUMOylation on the K292 residue of GSK 3 beta is a new mechanism for its functional regulation [ncbi , more ] in 2008 and Min Huei Liang et al. used Santa Cruz Biotechnology GSK3beta antibody to demonstrate that lithium suppresses Smad3/4-dependent TGF-beta-responsive gene transactivation [ncbi , more ]. In 2005, Shinichi Kosuga et al. employed Santa Cruz Biotechnology GSK3beta antibody to study the Phosphorylation and Activation of MARK2/PAR-1 by GSK-3 [ncbi , more ]. Jia Hao Xiao et al. utilized Santa Cruz Biotechnology GSK3beta antibody to detect GSK3beta in human HEK293 cells [ncbi , more ] in 2003 and Louis Ragolia et al. used Santa Cruz Biotechnology GSK3beta antibody to study the role of Lipocalin-type prostaglandin D2 synthase (L-PGDS) in maintaining the proper equilibrium between proliferation and apoptosis [ncbi , more ]. In 2002, Gregory I Liou et al. applied Santa Cruz Biotechnology GSK3beta antibody to study the role for MAP kinase and beta-catenin signaling in HGF induced RPE migration in human ARPE-19 cells and RPE cells [ncbi , more ]. In 2001, T Wada et al. utilized Santa Cruz Biotechnology GSK3beta antibody to study the effect of SH2-containing inositol phosphatase 2 in 3T3-L1 adipocytes [ncbi , more ].
BD Biosciences
  • immunocytochemistryIn 2005, Roman Kulikov et al. employed BD Biosciences GSK3beta antibody to investigate the regulation of p53 by GSK through MDM2 [ncbi , more ]. In 2004, Soheil Naderi et al. applied BD Biosciences GSK3beta antibody to detect GSK-3 beta in B-lymphoid precursor cell line, Reh [ncbi , more ].
  • immunoprecipitationIn 2007, Wen Luo et al. used BD Biosciences GSK3beta antibody to demonstrate protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex [ncbi , more ]. In 2005, Roman Kulikov et al. employed BD Biosciences GSK3beta antibody to investigate the regulation of p53 by GSK through MDM2 [ncbi , more ]. In 2004, Soheil Naderi et al. applied BD Biosciences GSK3beta antibody to detect GSK-3 beta in B-lymphoid precursor cell line, Reh [ncbi , more ]. In 2002, Stephan Bek et al. used BD Biosciences GSK3beta antibody to study the effect of protein kinase CKII on catenins [ncbi , more ].
  • western blotIn 2010, Saurabh Sahar et al. employed BD Biosciences GSK3beta antibody to investigate the role of CDC5 in the regulation of the checkpoint kinase Rad53 hyperphosphorylation [ncbi , more ]. In 2009, Ke Ning et al. employed BD Biosciences GSK3beta antibody to investigate the role of PTEN phosphorylation in the regulation of ATP-sensitive K+ channels [ncbi , more ]. In 2008, Katsuya Tanabe et al. utilized BD Biosciences GSK3beta antibody to study the role of Gsk-3beta in control of beta-cell mass in insulin-resistant diabetic models [ncbi , more ]. In 2007, Wen Luo et al. used BD Biosciences GSK3beta antibody to demonstrate protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex [ncbi , more ]. Roman Kulikov et al. employed BD Biosciences GSK3beta antibody to investigate the regulation of p53 by GSK through MDM2 [ncbi , more ] in 2005 and Jiyoung Park et al. used BD Biosciences GSK3beta antibody to study the association of glucose-6-phosphate dehydrogenase overexpression with lipid dysregulation and insulin resistance in obesity [ncbi , more ]. BD Biosciences GSK3beta antibody was used in 2004 to study Adenomatous Polyposis Coli down-regulation by the ubiquitin-proteasome pathway [ncbi , more ], to detect GSK-3 beta in B-lymphoid precursor cell line, Reh [ncbi , more ], to study expression of secreted frizzled-related protein 4 in normal and malignant human prostate tissue. [ncbi , more ], to study the opposing effect of thyroid-stimulating hormone/cAMP and glycogen synthase kinase 3beta on Rap1GAP stability in human embryonic kidney 293T cells [ncbi , more ]and to detect GSK-3beta in HeLa cells treated with or without calyculin A [ncbi , more ]. Gustavo Pigino et al. utilized BD Biosciences GSK3beta antibody to study the function of presenilin 1 mutations in kinesin-based axonal transport [ncbi , more ] in 2003 and Shin Ichiro Hino et al. used BD Biosciences GSK3beta antibody to study the role of casein kinase I epsilon in Dvl-1 and Frat-1 interaction and in beta-catenin accumulation [ncbi , more ]. Stephan Bek et al. used BD Biosciences GSK3beta antibody to study the effect of protein kinase CKII on catenins [ncbi , more ] in 2002 and Irene H L Hamelers et al. used BD Biosciences GSK3beta antibody to study the mechanism by which IGF-I induces the activation of the cyclin D1-CDK4 complex [ncbi , more ]. In 2001, A Reinacher-Schick et al. used BD Biosciences GSK3beta antibody to detect GSK-3 in human HCT116 colon carcinoma cells [ncbi , more ].
Sigma-AldrichSigma-Aldrich GSK3beta product
  • western blotIn 2005, Eyal Avraham et al. used Sigma-Aldrich GSK3beta antibody to study the role of glycogen synthase kinase 3 beta on synphilin-1 ubiquitylation [ncbi , more ].
Figure
Upstate Biotech anti-GSK3 was used to perform immunoprecipitation in order to show that p53 could be activated by GSK3beta through phosphorylation of S33.
GSK3beta antibody immunoprecipitation EMD Millipore
Ionizing Radiation inhibits GSK3beta kinase activity. SAOS-2 cells were immunoprecipitated with anti-GSK3 antibody and incubated with CREB phosphopeptide substrate. Total incorporated into the substrate peptide are shown. Pep: Assays carried out wit
G A Turenne et al. (2001). "Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity".PMID 11483158
Articles Reviewed
  1. Shu Yong Lin et al. (2012). "GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy".PMID 22539723
  2. Qing Li Kong et al. (2010). "Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma".PMID 20532215
  3. Yuping Luo et al. (2010). "Fragile x mental retardation protein regulates proliferation and differentiation of adult neural stem/progenitor cells".PMID 20386739
  4. Anna Lyubimova et al. (2010). "Neural Wiskott-Aldrich syndrome protein modulates Wnt signaling and is required for hair follicle cycling in mice".PMID 20071778
  5. Saurabh Sahar et al. (2010). "Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation".PMID 20049328
  6. Deliang Guo et al. (2009). "EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy".PMID 20009104
  7. Janice B B Lam et al. (2009). "Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities".PMID 19319191
  8. Melanie Konigshoff et al. (2009). "WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis".PMID 19287097
  9. Michel Varrin-Doyer et al. (2009). "Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration".PMID 19276087
  10. Young Jun Kim et al. (2009). "NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma".PMID 19237607
  11. Ke Ning et al. (2009). "Leptin-dependent phosphorylation of PTEN mediates actin restructuring and activation of ATP-sensitive K+ channels".PMID 19208634
  12. R Grant Rowe et al. (2009). "Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs".PMID 19188491
  13. Phillip R Kramer et al. (2009). "PI3K limits TNF-alpha production in CD16-activated monocytes".PMID 19180470
  14. Flora Brozzi et al. (2009). "S100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase: IMPLICATIONS FOR ASTROCYTE DEVELOPMENT, ACTIVATION, AND TUMOR GROWTH".PMID 19147496
  15. Vinicio A de Jesus Perez et al. (2009). "Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways".PMID 19139264
  16. Xia V Yang et al. (2009). "Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells".PMID 19116273
  17. Anna Dubrovska et al. (2009). "The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations".PMID 19116269
  18. Lee Eun Jeoung et al. (2008). "Regulation of glycogen synthase kinase 3beta functions by modification of the small ubiquitin-like modifier".PMID 18949077
  19. J R Smith et al. (2009). "Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors".PMID 18931700
  20. P L Greenhaff et al. (2008). "Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscle".PMID 18577697
  21. Myrto Giannopoulou et al. (2008). "Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling".PMID 18502824
  22. Melanie Konigshoff et al. (2008). "Functional Wnt signaling is increased in idiopathic pulmonary fibrosis".PMID 18478089
  23. Pawan Gulati et al. (2008). "Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34".PMID 18460336
  24. Chunrong Yu et al. (2008). "Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells".PMID 18445700
  25. Reginald L Austin et al. (2008). "siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle".PMID 18443205
  26. Nobuyuki Kikuno et al. (2008). "Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells".PMID 18431742
  27. Changxue Lu et al. (2008). "Activation of phosphatidylinositol 3-kinase signaling promotes aberrant pituitary growth in a mouse model of thyroid-stimulating hormone-secreting pituitary tumors".PMID 18356276
  28. Katsuya Tanabe et al. (2008). "Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance".PMID 18288891
  29. Min Huei Liang et al. (2008). "Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling".PMID 18077182
  30. Wen Luo et al. (2007). "Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex".PMID 17318175
  31. Mariko Tomita et al. (2006). "Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells".PMID 16603085
  32. Bruno Canguilhem et al. (2005). "RhoB protects human keratinocytes from UVB-induced apoptosis through epidermal growth factor receptor signaling".PMID 16278215
  33. Shinichi Kosuga et al. (2005). "GSK-3beta directly phosphorylates and activates MARK2/PAR-1".PMID 16257959
  34. Eyal Avraham et al. (2005). "Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation".PMID 16174773
  35. Roman Kulikov et al. (2005). "Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance".PMID 16055726
  36. Yen Chung Chen et al. (2005). "Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt".PMID 16036916
  37. Jiyoung Park et al. (2005). "Overexpression of glucose-6-phosphate dehydrogenase is associated with lipid dysregulation and insulin resistance in obesity".PMID 15923630
  38. Richard Seonghun Nho et al. (2005). "Role of integrin-linked kinase in regulating phosphorylation of Akt and fibroblast survival in type I collagen matrices through a beta1 integrin viability signaling pathway".PMID 15905178
  39. Kip M Connor et al. (2005). "Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation".PMID 15701646
  40. Michael N Corradetti et al. (2005). "The stress-inducted proteins RTP801 and RTP801L are negative regulators of the mammalian target of rapamycin pathway".PMID 15632201
  41. Hang Yin et al. (2005). "Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways".PMID 15611141
  42. Ho Young Lee et al. (2004). "Effects of insulin-like growth factor binding protein-3 and farnesyltransferase inhibitor SCH66336 on Akt expression and apoptosis in non-small-cell lung cancer cells".PMID 15494604
  43. Holger Buss et al. (2004). "Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity".PMID 15465828
  44. Jongkyu Choi et al. (2004). "Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin".PMID 15355978
  45. Joao T Barata et al. (2004). "Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells".PMID 15353558
  46. Soheil Naderi et al. (2004). "cAMP-induced degradation of cyclin D3 through association with GSK-3beta".PMID 15252116
  47. Lisa G Horvath et al. (2004). "Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro".PMID 14760084
  48. Oxana M Tsygankova et al. (2004). "Thyroid-stimulating hormone/cAMP and glycogen synthase kinase 3beta elicit opposing effects on Rap1GAP stability".PMID 14660640
  49. Gustavo Pigino et al. (2003). "Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport".PMID 12805290
  50. Jia Hao Xiao et al. (2003). "Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway".PMID 12771132
  51. Louis Ragolia et al. (2003). "Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells".PMID 12684506
  52. Jin Woo Kim et al. (2003). "Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1)".PMID 12584189
  53. Shin Ichiro Hino et al. (2003). "Casein kinase I epsilon enhances the binding of Dvl-1 to Frat-1 and is essential for Wnt-3a-induced accumulation of beta-catenin".PMID 12556519
  54. Gregory I Liou et al. (2002). "MAP kinase and beta-catenin signaling in HGF induced RPE migration".PMID 12500177
  55. Stephan Bek et al. (2002). "Protein kinase CKII regulates the interaction of beta-catenin with alpha-catenin and its protein stability".PMID 12432063
  56. Irene H L Hamelers et al. (2002). "Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells".PMID 12364325
  57. Daniel C Berwick et al. (2002). "The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes".PMID 12107176
  58. Bernardo Yusta et al. (2002). "Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase".PMID 11978789
  59. Fei Su et al. (2002). "WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase".PMID 11782444
  60. G A Turenne et al. (2001). "Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity".PMID 11483158
  61. E Avota et al. (2001). "Disruption of Akt kinase activation is important for immunosuppression induced by measles virus".PMID 11385511
  62. T Wada et al. (2001). "Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity".PMID 11238900
  63. A Reinacher-Schick et al. (2001). "Apical membrane localization of the adenomatous polyposis coli tumor suppressor protein and subcellular distribution of the beta-catenin destruction complex in polarized epithelial cells".PMID 11157977